| Code | CSB-MP004839HU |
| Abbreviation | Recombinant Human CCR1 protein-VLPs (Active) |
| MSDS | |
| Size | $620 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CCR1 mediates chemotactic responses to inflammatory chemokines including CCL3 (MIP-1α) and CCL5 (RANTES), making it a target of interest in cancer immunology and inflammatory disease research. This full-length receptor (aa 1–355) is presented in virus-like particles produced in mammalian cells, a format that preserves native membrane topology and post-translational modifications critical for conformational integrity of seven-transmembrane receptors. Functional ELISA validation demonstrates specific antibody binding with an EC50 of 9.69–10.94 ng/mL, confirming that the extracellular epitopes retain their native structure and supporting use in therapeutic antibody epitope mapping, competitive inhibition screening, and blocking antibody validation assays. With endotoxin levels below 1.0 EU/μg, this VLP-displayed receptor meets the quality thresholds commonly required for ligand-binding studies, receptor-ligand interaction characterization by surface plasmon resonance or biolayer interferometry, and small-molecule inhibitor screening campaigns targeting chemokine receptor pathways in oncology research.
There are currently no reviews for this product.